Quantum Genomics (Quantum Genomics) Additional Paid-In Capital : $15.47 Mil(As of Dec. 2022)

View and export this data going back to 2017. Start your Free Trial

What is Quantum Genomics Additional Paid-In Capital?

Quantum Genomics's quarterly additional paid-in capital declined from Dec. 2021 ($19.11 Mil) to Jun. 2022 ($15.53 Mil) but then stayed the same from Jun. 2022 ($15.53 Mil) to Dec. 2022 ($15.47 Mil).

Quantum Genomics's annual additional paid-in capital declined from Dec. 2020 ($33.79 Mil) to Dec. 2021 ($19.11 Mil) and declined from Dec. 2021 ($19.11 Mil) to Dec. 2022 ($15.47 Mil).

Quantum Genomics Additional Paid-In Capital Historical Data

The historical data trend for Quantum Genomics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantum Genomics Additional Paid-In Capital Chart

Quantum Genomics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Additional Paid-In Capital

Get a 7-Day Free Trial

50.00

13.17

33.79

19.11

15.47

Quantum Genomics Semi-Annual Data
	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
Additional Paid-In Capital	Get a 7-Day Free Trial															33.79	20.51	19.11	15.53	15.47

Quantum Genomics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Quantum Genomics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Quantum Genomics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Quantum Genomics (Quantum Genomics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quantum Genomics (OTCPK:QNNTF) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

ALQGC:France 2QG:Germany

Address

33, Rue Marbeuf, Paris, FRA, 75008

Website

https://quantum-genomics.com

Quantum Genomics is a biopharmaceutical company engaged in developing new products for unmet needs in the field of cardiovascular diseases, high blood pressure, and heart failure. The company products include firibastat, QGC006, QGC011, and others.